Please log in to determine if you are eligible to purchase PT Programs.
CAP/ACMG MITOCHONDRIAL CYTOPATHIES - IMD3
IMD3
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte/Procedure Challenges per Shipment Number of Shipments
Mitochondrial cytopathies* 3 Two shipments per year

*Includes disorders/diseases such as Leber hereditary optic neuropathy and myoclonus epilepsy with ragged red fibers (MERRF).


Program Information

  • Three 50.0‑μg extracted DNA specimens

Shipping Schedule

  • Shipment A: April 1
  • Shipment B: September 30